...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZCC as opposed to Zenith Epigenetics

,,,,,,hummmmmm,,,,,,,also remember that the Zenith team told us that our future course in 2016 would be >>>>>>

Future course
Internal development,
regional licensing and
co
-
development deals
will fuel value creation.
2015
-
2016
Share
New Message
Please login to post a reply